Is every article actually reviewed by a PharmD?
Yes. Every article that reaches subscribers has been manually reviewed and approved by a licensed pharmacist. AI generates the structured draft; the PharmD verifies clinical accuracy, selects the verdict, assigns the GRADE evidence rating, and decides what actually gets published. Articles that don't meet the bar are declined. They never reach your inbox.
How often do new analyses come out?
New articles are reviewed every day for inclusion based on clinical impact, study robustness, and accuracy. The number of published analyses varies by week depending on what's actually worth your time. Expect several per week during active publishing periods. Quality over volume.
What topics are covered?
Cardiology/anticoagulation, infectious disease/antimicrobials, oncology pharmacy, ambulatory care/MTM, medication safety, pharmacokinetics/TDM, clinical pharmacy practice, critical care/ICU, pediatric pharmacy, and more. New specialty areas are added regularly as coverage expands. Topic preferences let paid subscribers filter to only what's relevant to their practice.
How is this different from a journal alert or PubMed RSS feed?
A journal alert gives you a title and abstract. PharmD Signal gives you a structured clinical breakdown with study design, results tables, safety data, GRADE evidence rating, and pharmacist-specific implications, reviewed by a clinician, not just indexed by an algorithm. It's the difference between raw data and a usable clinical tool.
How do I cancel or manage my paid subscription?
Log in and go to your Account page. The Manage Subscription & Billing link takes you to a secure self-service portal where you can update your card, view invoices, or cancel anytime. Cancelling stops future renewals; you keep access through the end of your current paid period.